$22.49
0.241.07%
In chiusura: -
$22.25
-0.24-1.06%
After hour: May 12, 9:29 AM EDT
Tema Neuroscience and Mental Health ETF (NASDAQ: MNTL)
Ticker | Name | Share % | |
---|---|---|---|
VRTX | Vertex Pharmaceuticals Inc | 11.19% | |
REGN | Regeneron Pharmaceuticals, Inc. | 7.56% | |
LLY | Eli Lilly & Co. | 4.38% | |
ALNY | Alnylam Pharmaceuticals Inc. | 5.00% | |
AS | Argenx Se Spon Adr Each Rep 1 Ord Shs | 5.62% | |
NBIX | Neurocrine Biosciences Inc | 4.16% | |
DNLI | Denali Therapeutics Inc | 4.18% | |
BIIB | Biogen Inc. | 3.00% | |
IL | Teva Pharmaceutical Industries Ltd Sponsored Adr | 4.54% | |
CRNX | Crinetics Pharmaceuticals Inc Com | 4.29% | |
SYK | Stryker Corp | 2.93% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
MNTL segue uno stile di investimento Mid Cap Blend.
Le principali posizioni di MNTL includono: VRTX (11.19%), REGN (7.56%), LLY (4.38%), ALNY (5%), AS (5.62%). Queste rappresentano le posizioni più grandi nel portafoglio dell'ETF.
I dati del volume medio giornaliero per MNTL non sono attualmente disponibili.